TrialBlood advances2024

Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study.

Peter Bader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.